Cargando…
Efficacy and Safety of Perindopril in Patients with Essential Hypertension
INTRODUCTION: Perindopril is a tissue-specific ACE inhibitor with 24 hours long blood pressure-lowering effect, which protects blood vessels and decreases the variability of blood pressure. AIM: The aim of our study was to investigate the effectiveness and safety of perindopril in newly diagnosed or...
Autores principales: | Hodzic, Enisa, Pecar, Ehlimana, Dzubur, Alen, Smajic, Elnur, Hondo, Zorica, Delic, Daniela, Rustempasic, Edhem |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
AVICENA, d.o.o., Sarajevo
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7219713/ https://www.ncbi.nlm.nih.gov/pubmed/32410885 http://dx.doi.org/10.5455/msm.2020.32.4-9 |
Ejemplares similares
-
The Cumulative Incidence of Stroke, Myocardial infarction, Heart Failure and Sudden Cardiac Death in Patients with Atrial Fibrillation
por: Naser, Nabil, et al.
Publicado: (2017) -
Pulmonary Hypertension – New Trends of Diagnostic and Therapy
por: Pesto, Senad, et al.
Publicado: (2016) -
Predictors of Hospitalization for Heart Failure Decompensation in 18-months Follow-up After Index Hospitalization for Acute Heart Failure
por: Durak-Nalbantic, Azra, et al.
Publicado: (2018) -
Perindopril: the evidence of its therapeutic impact in hypertension
por: Thomson, Andrew, et al.
Publicado: (2007) -
The Efficacy and Tolerability of a Fixed Combination of Perindopril and Indapamide in the Treatment of Unregulated Essential Hypertension – a Post-marketing Study
por: Šukalo, Aziz, et al.
Publicado: (2022)